DURHAM, N.C.-- Patenting of genes has not resulted in a pattern of exorbitant pricing or restricted access to tests for diseases such as Alzheimer’s and breast cancer, Duke University researchers report in Wednesday’s Nature magazine. However, genetic testing monopolies are creating significant problems, say authors Robert Cook-Deegan, Subhashini Chandrasekharanand Misha Angrist.